Home Equities Score Purple Biotech Ltd. (PPBT) Stock Undergoes Minor Volatility Amid Progression of CM24...

Purple Biotech Ltd. (PPBT) Stock Undergoes Minor Volatility Amid Progression of CM24 Clinical Trial

Purple Biotech Ltd. (PPBT) stock prices were up by 2.15% as of the market closing on May 26th, 2021, bringing the price per share up to USD$4.76 at the end of the trading day. Subsequent pre-market fluctuations saw the price dip by a marginal 1.05%, bringing it down to USD$4.71.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

CM24 Trial Commences Patient Dosing

The company announced on April 23rd, 2021 that the first dosing of the first patient in the Phase 1b/2 clinical trial of CM24, a monoclonal antibody blocking CEACAM1. The treatment was administered in conjunction with the PD-1 inhibitor, nivolumab, in patients with advanced cancer. The study had expansion cohorts in subjects with non-small cell lung cancer (NSCLC) and pancreatic cancer.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


Read More

CM24 Trial

The initial dosing of the first patient as a part of the study being conducted in clinical collaboration with Bristol Myers Squibb is a critical milestone in the development of CM24. The targeting of CEACAM1 is an innovative approach that makes use of up-to-date knowledge of the interface of the myeloid and T-cell systems in the neoplastic phenotype. The company is keenly anticipating the availability of preliminary data from the first part of the study before the end of the fiscal year.

Phase 1b

The Phase 1b/2 clinical trial reported having expansion cohorts in subjects with pancreatic cancer and NSCLC. The dosage of CM24 will be doubled from 10 to 20mg/kg and will be administered in combination with nivolumab in Phase 1b. Patients who the dose will be administered to will have NSCLC, pancreatic cancer, ovarian carcinoma, colorectal adenocarcinoma, melanoma, or thyroid carcinoma. The primary objective of the upped dosage in the study will be to evaluate the safety of CM24, PK, and determining the recommended Phase 2 dose.

Phase 2

The Phase 2 component of the study will see CM24 and nivolumab being used to treat patients with NSCLC after first-line immune-oncology failure. Patients with metastatic pancreatic adenocarcinoma will be administered the same mix plus nab-paclitaxel after first-line therapy failure. The study will have safety and preliminary efficacy as its endpoints. Potential biomarkers such as CEACAM1 level of expression and a host of other immune and adhesion-related molecules will be evaluated as a part of the study.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for PPBT

With the development of CM24 underway, PPBT is poised to capitalize on the pending FDA approval and commercialization of the treatment. The company is keen to push for the commercialization of its leading drug candidate in an effort to facilitate further growth. Current and potential investors are hopeful that the company will manage to leverage the resources at its disposal to facilitate significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Vertex Pharmaceuticals Inc. (VRTX) stock plunged during after-hour. Here’s what you should know

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) stock gained by 1.5% at last close while the VRTX stock price declines during after-hour by 12.95%. Vertex is...

Bit Digital Inc. (BTBT) stock plunges during the current market trading session. What is happening?

Bit Digital Inc. (NASDAQ: BTBT) stock declined by -1.43% in the current market trading as of this writing. Bit Digital, Inc. is a Bitcoin...

Celsion Corporation (CLSN) stock gains in Pre-Market: Let’s Find out why.

Shares of Celsion Corporation (CLSN) stock were gaining in the pre-market today on June 10, 2021, following the announcement of new appointments by Celsion...

Medley Management Inc. (MDLY) stock soars during pre-market trading, given no recent update

Medley Management Inc. (NASDAQ: MDLY) stock gained by 8.96% at last close while the MDLY stock price rises by 108.90% in the pre-market trading...

Sphere 3D Corp. (ANY) stock surged during after-hour session. Why so?

Sphere 3D Corp. (NASDAQ: ANY) stock gained by 10.5% at last close while the ANY stock price soars further during the after-hour session by...


Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam